New Zealand - English - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract); allergen extracts 1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract); allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) - solution for injection - active: allergen extracts 0.1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water - alustal treatment is indicated for patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis with or without associated asthma.

New Zealand - English - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water - alustal treatment is indicated for patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis with or without associated asthma.

New Zealand - English - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ic/ml (chenopodium album pollen extract); allergen extracts 1 ic/ml (chenopodium album pollen extract); allergen extracts 10 ic/ml (chenopodium album pollen extract) - solution for injection - active: allergen extracts 0.1 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - English - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ic/ml (chenopodium album pollen extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - English - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts); allergen extracts 1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts); allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) - solution for injection - active: allergen extracts 0.1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - English - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - English - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 1 ic/ml (plantago lanceolata pollen extract); allergen extracts 1 ic/ml (plantago lanceolata pollen extract); allergen extracts 10 ic/ml (plantago lanceolata pollen extract) - solution for injection - active: allergen extracts 1 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - English - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ic/ml (plantago lanceolata pollen extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - sacubitril/valsartan 50mg (as sodium hydrate complex, contains 24.3 mg sacubitril and 25.7 mg valsartan);  ;   - film coated tablet - 24.3 mg/25.7 mg - active: sacubitril/valsartan 50mg (as sodium hydrate complex, contains 24.3 mg sacubitril and 25.7 mg valsartan)     excipient: colloidal silicon dioxide crospovidone hyprolose basic coating premix, white basic coating premix, red basic coating premix, black magnesium stearate microcrystalline cellulose purified talc purified water - entresto is indicated in adult patients with chronic heart failure (nyha class ii-iv). benefits are most clearly evident in patients with left ventricular ejection fraction (lvef) below normal. lvef is a variable measure, so use clinical judgment in deciding whom to treat

Israel - English - Ministry of Health

gamida care ltd., israel - alergens (chemical) 24 - plaster for provocation test - alergens (chemical) 24 - various - diagnosis of allergic contact dermatitis.